News
FDA, COVID and vaccine
Digest more
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
3d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results